Stockreport

Alexion to study rare blood-disorder drug in severe COVID-19 patients [Reuters]

Alexion Pharmaceuticals, Inc  (ALXN) 
Last alexion pharmaceuticals, inc earnings: 1/30 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.alexion.com/investor-relations
PDF Alexion to study rare blood-disorder drug in severe COVID-19 patients (Reuters) - Alexion Pharmaceuticals Inc said on Monday it would start a late-stage study of its rar [Read more]